Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shah, P.
Right arrow Articles by Rizza, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, P.
Right arrow Articles by Rizza, R. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 51:301-310, 2002
© 2002 by the American Diabetes Association, Inc.

Effects of Free Fatty Acids and Glycerol on Splanchnic Glucose Metabolism and Insulin Extraction in Nondiabetic Humans

Pankaj Shah, Adrian Vella, Ananda Basu, Rita Basu, Aron Adkins, W. Frederick Schwenk, C. Michael Johnson, K. Sreekumaran Nair, Michael D. Jensen, and Robert A. Rizza

From the Endocrine Research Unit, Mayo Clinic and Foundation, Rochester, Minnesota

The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the ability of insulin and glucose to regulate splanchnic as well as muscle glucose metabolism. To do so, FFAs were increased in 10 subjects to ~1 mmol/l by an 8-h Intralipid/heparin (IL/Hep) infusion, whereas they fell to levels near the detection limit of the assay (<0.05 mmol/l) in 13 other subjects who were infused with glycerol alone at rates sufficient to either match (n = 5, low glycerol) or double (n = 8, high glycerol) the plasma glycerol concentrations observed during the IL/Hep infusion. Glucose was clamped at ~8.3 mmol/l, and insulin was increased to ~300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. Leg glucose uptake (21.7 ± 3.5 vs. 48.3 ± 9.3 and 57.8 ± 11.7 µmol · kg-1 leg · min-1) was lower (P < 0.001) during IL/Hep than the low- or high-glycerol infusions, confirming that elevated FFAs caused insulin resistance in muscle. IL/Hep did not alter splanchnic glucose uptake or the contribution of the extracellular direct pathway to UDP-glucose flux. On the other hand, total UDP-glucose flux (13.2 ± 1.7 and 12.5 ± 1.0 vs. 8.1 ± 0.5 µmol · kg-1 · min-1) and flux via the indirect intracellular pathway (8.4 ± 1.2 and 8.1 ± 0.6 vs. 4.8 ± 0.05 µmol · kg-1 · min-1) were greater (P < 0.05) during both the IL/Hep and high-glycerol infusions than the low-glycerol infusion. In contrast, only IL/Hep increased (P < 0.05) splanchnic glucose production, indicating that elevated FFAs impaired the ability of the liver to autoregulate. Splanchnic insulin extraction, directly measured using the arterial and hepatic vein catheters, did not differ (67 ± 3 vs. 71 ± 5 vs. 69 ± 1%) during IL/Hep and high- and low-glycerol infusions. We conclude that elevated FFAs exert multiple effects on glucose metabolism. They inhibit insulin- and glucose-induced stimulation of muscle glucose uptake and suppression of splanchnic glucose production. They increase the contribution of the indirect pathway to glycogen synthesis and impair hepatic autoregulation. On the other hand, they do not alter either splanchnic glucose uptake or splanchnic insulin extraction in nondiabetic humans.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. J. Meier, J. J. Holst, W. E. Schmidt, and M. A. Nauck
Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E849 - E856.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al.
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Dhindsa, D. Tripathy, N. Sanalkumar, S. Ravishankar, H. Ghanim, A. Aljada, and P. Dandona
Free Fatty Acid-Induced Insulin Resistance in the Obese Is Not Prevented by Rosiglitazone Treatment
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5058 - 5063.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. J. Meier, J. D. Veldhuis, and P. C. Butler
Pulsatile Insulin Secretion Dictates Systemic Insulin Delivery by Regulating Hepatic Insulin Extraction In Humans
Diabetes, June 1, 2005; 54(6): 1649 - 1656.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Endocr. Rev., October 1, 2004; 25(5): 807 - 830.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Iozzo, A. K. Turpeinen, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti
Defective Liver Disposal of Free Fatty Acids in Patients with Impaired Glucose Tolerance
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3496 - 3502.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Basu, W. F. Schwenk, and R. A. Rizza
Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Fery, L. Tappy, J. Deviere, and E. O. Balasse
Comparison of intraduodenal and intravenous glucose metabolism under clamp conditions in humans
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E176 - E183.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. C. Moore, S. Satake, M. Lautz, S. A. Soleimanpour, D. W. Neal, M. Smith, and A. D. Cherrington
Nonesterified Fatty Acids and Hepatic Glucose Metabolism in the Conscious Dog
Diabetes, January 1, 2004; 53(1): 32 - 40.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Iozzo, K. Hallsten, V. Oikonen, K. A. Virtanen, R. Parkkola, J. Kemppainen, O. Solin, F. Lonnqvist, E. Ferrannini, J. Knuuti, et al.
Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Their Relation to Visceral Fat in Type 2 Diabetes
Diabetes Care, July 1, 2003; 26(7): 2069 - 2074.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Bajaj, S. Suraamornkul, T. Pratipanawatr, L. J. Hardies, W. Pratipanawatr, L. Glass, E. Cersosimo, Y. Miyazaki, and R. A. DeFronzo
Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes
Diabetes, June 1, 2003; 52(6): 1364 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. J. Woerle, C. Meyer, E. M. Popa, P. E. Cryer, and J. E. Gerich
Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes: Further Evidence for Hepatorenal Reciprocity
Diabetes, June 1, 2003; 52(6): 1386 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza
Elevated Free Fatty Acids Impair Glucose Metabolism in Women: Decreased Stimulation of Muscle Glucose Uptake and Suppression of Splanchnic Glucose Production During Combined Hyperinsulinemia and Hyperglycemia
Diabetes, January 1, 2003; 52(1): 38 - 42.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Bajaj, T. Pratipanawatr, R. Berria, W. Pratipanawatr, S. Kashyap, K. Cusi, L. Mandarino, and R. A. DeFronzo
Free Fatty Acids Reduce Splanchnic and Peripheral Glucose Uptake in Patients With Type 2 Diabetes
Diabetes, October 1, 2002; 51(10): 3043 - 3048.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Singhal, A. Caumo, P. E. Carey, C. Cobelli, and R. Taylor
Regulation of endogenous glucose production after a mixed meal in type 2 diabetes
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E275 - E283.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Bajaj, R. Berria, T. Pratipanawatr, S. Kashyap, W. Pratipanawatr, R. Belfort, K. Cusi, L. Mandarino, and R. A. DeFronzo
Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E346 - E352.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.